What is supplement substantiation?

Substantiation is the process of gathering and documenting scientific evidence that supports the health claims you make on your supplement labels and marketing materials. The FDA requires that all structure–function claims be truthful, non-misleading, and substantiated by competent and reliable scientific evidence — typically clinical trials on healthy human subjects.

How does Nutra Comp's AI analysis work?

Nutra Comp searches PubMed for clinical trials relevant to your ingredient, filters for studies on healthy human subjects with oral administration, and uses AI to extract key data: p-values, effect sizes, study design, population details, and conclusions. It distinguishes between across-group and within-group significance and ranks evidence strength with a confidence scoring system.

What data sources does Nutra Comp use?

Nutra Comp primarily searches PubMed/MEDLINE, the world's largest biomedical literature database maintained by the U.S. National Library of Medicine. We focus on peer-reviewed clinical trials, randomised controlled trials (RCTs), meta-analyses, and systematic reviews.

Are the generated claims FDA-compliant?

Yes. Nutra Comp generates structure–function claims in strict accordance with the FDA Small Entity Compliance Guide. All claims avoid explicit and implicit disease references. However, we recommend having your legal/regulatory team review the final output before use, as Nutra Comp is a tool to assist — not replace — professional compliance review.

How long does a typical ingredient search take?

Most ingredient searches complete within 5–15 minutes, depending on the volume of clinical literature available. Compare this to the typical manual process which can take 40–100+ hours per ingredient when done by a human compliance expert.

Can I export my reports?

Absolutely. All clinical evidence reports, structure–function claims, and substantiation memos can be exported as professional PDF documents. These are formatted for easy sharing with your legal team, regulatory reviewers, or business partners.

What does 'ingredient searches per month' mean?

Each search is one ingredient analysis — for example, searching 'Ashwagandha' or 'Vitamin D3'. The search generates a complete evidence report, claims, and substantiation memo for that ingredient. Your monthly allowance resets on your billing date.

When will Nutra Comp be available?

We're currently in private beta. Join the waitlist to get early access and be notified when we launch. Early waitlist members will receive priority access and special launch pricing.

Alpha-Lipoic Acid (ALA): Clinical Evidence & Substantiation Summary

Clinical Trials

Strongest Evidence

Blood Sugar Support

Typical Dosage

300–600 mg/day

Common Forms

R-lipoic acid (R-ALA)

What Is Alpha-Lipoic Acid (ALA)?

Alpha-lipoic acid is a unique antioxidant that is both water- and fat-soluble, enabling it to function in every cell compartment. It plays a key role in mitochondrial energy metabolism and has clinical evidence for blood sugar support and neuroprotection.

Mechanism of action: ALA serves as a cofactor for mitochondrial enzymes (pyruvate dehydrogenase, α-ketoglutarate dehydrogenase) and is a potent antioxidant that regenerates other antioxidants (vitamin C, vitamin E, glutathione). It activates AMPK, enhances glucose uptake, and chelates heavy metals.

Clinical Evidence Summary

Below are 5 key clinical studies on Alpha-Lipoic Acid (ALA). Nutra Comp analyses 52+ studies in its full clinical evidence report.

Meta-analysis2015PMID: 25688926

Alpha-lipoic acid and glycemic control: a meta-analysis

Population: 12 RCTs, 906 participants

Key finding: ALA supplementation significantly reduced fasting glucose (WMD: -10.9 mg/dL, p<0.001) and HbA1c (WMD: -0.38%, p=0.002).

Systematic review and meta-analysis2017PMID: 28219059

ALA for diabetic neuropathy: systematic review

Population: 15 RCTs

Key finding: ALA (600 mg/day) significantly improved neuropathy symptom scores and nerve conduction velocities (p<0.01).

Meta-analysis2015PMID: 26502953

Antioxidant effects of alpha-lipoic acid supplementation

Population: 10 RCTs

Key finding: ALA significantly increased total antioxidant capacity and reduced MDA (a lipid peroxidation marker) vs. placebo (p<0.001).

Meta-analysis2019PMID: 31142457

Alpha-lipoic acid and weight management

Population: 10 RCTs, 564 participants

Key finding: ALA supplementation led to modest but significant weight loss (WMD: -1.27 kg, p=0.02) compared with placebo.

Meta-analysis2018PMID: 29307925

ALA and inflammatory markers

Population: 8 RCTs

Key finding: ALA supplementation significantly reduced CRP (WMD: -0.48 mg/L, p=0.01) and TNF-α levels.

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

“Supports healthy blood sugar metabolism”

Category: Blood Sugar · Confidence: 8/10

“Provides antioxidant support in both water and fat environments”

Category: Antioxidant · Confidence: 9/10

“Supports healthy nerve function”

Category: Nervous System · Confidence: 7/10

Get the full substantiation report for Alpha-Lipoic Acid (ALA)

Includes all 52+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Berberine

47 studies · Blood Sugar Support

Coenzyme Q10 (CoQ10)

68 studies · Cardiovascular Health

Chromium

64 studies · Blood Sugar Management

Key Terms

Randomised Controlled Trial (RCT)Meta-Analysis Clinically Effective Dose

Frequently Asked Questions

Is alpha-lipoic acid FDA approved?

ALA is sold as a dietary supplement in the US. In Europe, it is approved as a prescription drug for diabetic neuropathy. As a supplement, it does not require FDA approval.

What are the most studied benefits of ALA?

The strongest evidence supports ALA for blood sugar metabolism, antioxidant protection, and nerve function support. It is particularly well-studied for peripheral neuropathy.

What dosage of ALA is used in clinical studies?

Most studies use 300–600 mg/day. For neuropathy studies, 600 mg/day is standard. R-lipoic acid (the natural form) is considered more bioactive than the racemic mixture.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist